mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |